Monthly HIV shot offers escape from daily pill Health 3 hours ago
A discrete choice experiment conducted among 700 people with HIV at Kenyatta National Hospital and two sex worker outreach clinics in Nairobi found that patients living with HIV in Kenya expressed clear preferences for long-acting antiretroviral therapies over daily oral regimens, citing potential to improve adherence and achieve viral suppression.
According to the findings, monthly injections of cabotegravir combined with rilpivirine, two antiretroviral drugs delivered as a long-acting injectable formulation, were superior to continued daily oral antiretroviral therapy in reducing treatment failure among people with HIV who had documented adherence challenges.
People living with HIV who struggle to take daily medication and maintain an undetectable viral load may soon have a far more manageable option: a monthly injection.
This is a summary of the original articles listed below. Always read the source articles for the full context. GhanaSummary does not create or modify the news — we summarise and link to original publishers.
Original Sources (1)
More from Kenya
Degrees of debt: Ruto's new varsity funding plan to drown students in debts
Gachagua proposes 'hyenas coalition' to beat Ruto following Duale slur Politics Just now Listen
PREMIUM Senators furious with IG Kanja over Isiolo Governor Guyo Warrant of arrest against Governor Guyo was issued by Senate committee after he snubbed a summon. News 15 min ago Listen